Stoke Therapeutics, Inc. (STOK)

Stoke Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 11, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	2,033	1,870	596	242	364	885
Market Cap Growth	276.86%	213.80%	146.75%	-33.65%	-58.88%	-60.92%
Enterprise Value	1,625	1,585	379.01	40.14	134.43	665.48
Last Close Price	32.64	31.74	11.03	5.26	9.23	23.99
PE Ratio	-	-264.50	-6.68	-2.21	-3.55	-10.25
PS Ratio	63.37	10.14	16.30	27.51	29.35	-
PB Ratio	5.14	5.31	2.60	1.51	1.97	4.07
P/TBV Ratio	4.87	5.33	2.60	1.45	1.94	4.05
P/FCF Ratio	-	41.64	-6.85	-2.92	-10.16	-13.00
P/OCF Ratio	-	41.03	-6.86	-2.98	-11.42	-13.23
EV/Sales Ratio	50.66	8.59	10.37	4.57	10.84	-
EV/EBITDA Ratio	-	-84.22	-3.82	-0.36	-1.31	-7.82
EV/EBIT Ratio	-	-76.98	-3.74	-0.35	-1.29	-7.73
EV/FCF Ratio	-	35.29	-4.35	-0.49	-3.75	-9.77
Net Debt / Equity Ratio	-0.87	-0.81	-0.95	-1.26	-1.24	-1.01
Net Debt / EBITDA Ratio	1.87	15.15	2.19	1.79	2.23	2.58
Net Debt / FCF Ratio	2.33	-6.35	2.49	2.44	6.41	3.23
Asset Turnover	0.07	0.53	0.15	0.04	0.05	0
Quick Ratio	8.57	5.06	5.48	6.54	7.33	12.83
Current Ratio	8.99	5.28	5.81	6.99	7.77	13.37
Return on Equity (ROE)	-45.43%	-2.37%	-45.80%	-60.80%	-50.20%	-34.06%
Return on Assets (ROA)	-42.67%	-5.97%	-40.56%	-47.39%	-42.17%	-32.07%
Return on Invested Capital (ROIC)	-235.29%	-34.09%	-451.00%	-1072.85%	-1757.72%	-15535.20%
Return on Capital Employed (ROCE)	-48.56%	-6.96%	-47.26%	-54.37%	-46.75%	-33.87%
Earnings Yield	-8.35%	-0.38%	-14.96%	-45.25%	-28.17%	-9.75%
FCF Yield	-7.27%	2.40%	-14.61%	-34.23%	-9.84%	-7.69%
Buyback Yield / Dilution	-5.62%	-9.65%	-22.76%	-13.10%	-5.87%	-9.71%
Total Shareholder Return	-5.62%	-9.65%	-22.76%	-13.10%	-5.87%	-9.71%

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q